DISEASE ACTIVITY AND CLINICAL RESPONSE EARLY IN THE COURSE OF TREATMENT PREDICTS LONG-TERM OUTCOMES IN AXIAL SPONDYLOARTHRITIS AND PSORIATIC ARTHRITIS PATIENTS TREATED WITH CERTOLIZUMAB PEGOL
Author(s):
Heijde, D. van der; Deodhar, A.; Fleischmann, R.; Rudwaleit, M.; Davies, O.; Nurminen, T.; Mease, P.J.
Published
2014
Publication type
Article / Letter to editor
Date issued
2014-10-31
Language
English
Is part of
Clinical and Experimental Rheumatology (2014), Vol. 32, no. 5, p. 786-786
